Trials funded by Novo Nordisk have shown a mean weight loss of up to 15% from oral semaglutide in adults without diabetes
Charbel C, Fontaine RH, Malouf GG, Picard A, Kadlub N, El-Murr N, et al
IGF-1 Production and Downstream Effects Once growth hormone is released, it stimulates the liver and other tissues to produce IGF-1
Over five million patients are treated with TS inhibitors annually 89,90 , expanding our findings beyond the CRC field to other disease indications that use pemetrexed or methotrexate, such as lung cancer
The exendin-4 treatment has been shown to reduce cocaine self-administration, suggesting that the GLP-1 system may be a novel target of drug addiction (Sorensen et al., 2015)